2024 Partners
Charles River Laboratories
Founded in 1947, Charles River Laboratories is the leading global drug development partner. Over the past 5 years, Charles River has supported the research and development of over 80% of the new drugs approved by the FDA.
Biologics Testing Solutions
With more than 50 years of experience and over 40,000 tests run annually at the GMP biologics testing facilities; Charles River can provide comprehensive testing services for a wide range of modalities.
Cell and Gene Therapy CDMO Solutions
We have supported the development of 20 FDA-approved cell and gene therapies and have conducted more than 1000 studies in this field over the past year. Our unsurpassed end-to-end offering results in enhanced access to scientific and regulatory expertise via our multidisciplinary bench of experts to help your problem solve.
Eureka Bio
Eurekabio stands as a pioneering force in the realm of cell and gene therapy, serving as a leading upstream core supplier. Our primary focus lies in the research and development of pivotal biotechnology and autonomous equipment in the field of gene and cell therapy (CGT). By seamlessly integrating automation technology, artificial intelligence, and diverse disciplines with biotechnology, we have successfully addressed crucial technological challenges in gene therapy, cell therapy, life science, and pharmaceutical R&D.
Through the synergies of cross-disciplinary collaboration and technological innovation, Eurekabio has consistently pushed the boundaries of therapy.
Eurekabio has brought forth advanced cellular drug production solutions and the EuLV lentiviral vector platform. These breakthroughs, including high-titer stable lentiviral vector packaging and producer cell lines, are poised to play a pivotal role in the global commercialization of CGT drugs. Our ultimate aim is to bring tangible benefits to patients worldwide by ushering in a new era of advanced and accessible therapies.